台股 » 奈米醫材 » 個股財報 » 每股盈餘成長率(季增率)
- 股價
84.0
- 漲跌
▲0.1
- 漲幅
+0.12%
- 成交量
3張
- 產業
上櫃 生技醫療類股
-
本地時間:13:30(已收盤)
奈米醫材 (6612) 財務報表－每股盈餘成長率(季增率)
EPS成長率
EPS季增率 = (單季EPS÷上季EPS)-1。
EPS年增率 = (單季EPS÷去年同季EPS)-1。
奈米醫材 (6612) EPS季增率與季收盤價比較圖
奈米醫材 (6612) 歷年EPS季增率
| 年度/季別 | EPS季增率 | 近4季EPS季增率 | 年度/季別 | EPS季增率 | 近4季EPS季增率 |
|---|
| 2025Q3 | -112.5% | -29.86% | 2022Q3 | 76.54% | 30% |
| 2025Q2 | -136.04% | -25.84% | 2022Q2 | -7.95% | 22.95% |
| 2025Q1 | 40.51% | 23.65% | 2022Q1 | 12.82% | 40.23% |
| 2024Q4 | 11.27% | 82.58% | 2021Q4 | 47.17% | 85.11% |
| 2024Q3 | 91.89% | -18.01% | 2021Q3 | 112% | -12.96% |
| 2024Q2 | -31.48% | -30.6% | 2021Q2 | 38.89% | 4.85% |
| 2024Q1 | -280% | -9.02% | 2021Q1 | -1000% | -33.55% |
| 2023Q4 | -130% | -27.97% | 2020Q4 | -102.99% | -26.54% |
| 2023Q3 | -7.41% | -10.83% | 2020Q3 | 235% | -4.95% |
| 2023Q2 | 40.26% | 7.3% | 2020Q2 | -71.43% | -23.71% |
| 2023Q1 | 11.59% | -2.89% | 2020Q1 | 29.63% | 19.75% |
| 2022Q4 | -51.75% | -2.31% | | | |